- Home
- FNWB vs CRVO Comparison
FNWB vs CRVO Comparison
Compare FNWB & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- CRVO
- Stock Information
- Founded
- FNWB 1923
- CRVO 2001
- Country
- FNWB United States
- CRVO United States
- Employees
- FNWB N/A
- CRVO N/A
- Industry
- FNWB Banks
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- CRVO Health Care
- Exchange
- FNWB Nasdaq
- CRVO Nasdaq
- Market Cap
- FNWB 84.1M
- CRVO 69.3M
- IPO Year
- FNWB 2015
- CRVO N/A
- Fundamental
- Price
- FNWB $8.40
- CRVO $7.39
- Analyst Decision
- FNWB Hold
- CRVO Strong Buy
- Analyst Count
- FNWB 1
- CRVO 8
- Target Price
- FNWB $12.00
- CRVO $25.57
- AVG Volume (30 Days)
- FNWB 15.5K
- CRVO 201.8K
- Earning Date
- FNWB 07-24-2025
- CRVO 05-12-2025
- Dividend Yield
- FNWB 3.22%
- CRVO N/A
- EPS Growth
- FNWB N/A
- CRVO N/A
- EPS
- FNWB N/A
- CRVO N/A
- Revenue
- FNWB $45,593,000.00
- CRVO $9,308,215.00
- Revenue This Year
- FNWB $37.97
- CRVO N/A
- Revenue Next Year
- FNWB $13.22
- CRVO N/A
- P/E Ratio
- FNWB N/A
- CRVO N/A
- Revenue Growth
- FNWB N/A
- CRVO 15.14
- 52 Week Low
- FNWB $8.26
- CRVO $1.80
- 52 Week High
- FNWB $12.10
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- FNWB 33.59
- CRVO 43.32
- Support Level
- FNWB $8.16
- CRVO $7.01
- Resistance Level
- FNWB $9.37
- CRVO $8.60
- Average True Range (ATR)
- FNWB 0.27
- CRVO 0.53
- MACD
- FNWB -0.08
- CRVO -0.10
- Stochastic Oscillator
- FNWB 23.31
- CRVO 35.53
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.